North America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiologic

North America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) 

The lymphedema treatment market in North America is expected to grow from US$ 3,880.04 million in 2021 to US$ 5,419.77 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028. One report states that treatment plans are designed for determining the stages and causes of the condition. For example, surgeons performed several reconstructive surgical interventions, including vascularized lymph node transfer, lymphovenous bypass, and a type of liposuction for reducing swelling. Additionally, the non-surgical techniques include complete decongestive therapy (CDT). Several hospitals are equipped with beds that perform CDP on patients due to satisfactory medical coverage. New tests, coupled with technological advancements, play a critical role in controlling the prevalence of lymphedema cases among patients. On the other hand, the lymphedema management program provides services related to physical and occupational therapists that have been extensively trained in skilled treatment techniques for lymphedema management. One major company has developed a rehabilitation program based on therapists' training and working knowledge of current medical management of primary and secondary lymphedema with rehabilitative needs. Further, services by physical and occupational therapists are brought together for developing a personalized treatment plan for restoring the patient to the highest level of functioning. Such an innovative rehabilitation program aims to educate and instruct patients about self-assist techniques for independently managing primary and secondary lymphedema. Thus, increasing healthcare services and lymphedema management programs is fueling the market growth.

The secondary lymphedema segment led the North America lymphedema treatment market, based on condition type, in 2020. Secondary lymphedema is an acquired disorder resulting from obstruction or damage to the lymphatic system. Also, secondary lymphedema may occur owing to trauma, tumors, or after radiation therapy for cancer or surgery for removing lymph nodes. Apart from that, the report states that, secondary lymphedema is associated with adverse physical and psychological consequences among women with breast cancer (BC). Therefore, the secondary lymphedema is arguably the most problematic and associated complications of breast cancer treatment. For instance, the incidence is generally accepted at approx. 30% and reported vary greatly ranging between 2% and 83%. Moreover, the Frontiers S.A. report states that currently secondary lymphedema is more common due to increasing cancer rates, affecting 1 in 1,000 persons where 24-49% of cancer patients develop secondary lymphedema post receiving cancer treatment.

The world had watched several viruses such as SARS, H1N1, and others over the past few years. However, the severity of the coronavirus made the condition difficult. Coronavirus disease (COVID-19) is a contagious disease that has been affected by a newly discovered coronavirus. In the North American region, the United States was heavily impacted by the the COVID-19 pandemic. The country had the highest number of positive cases. COVID-19, first discovered in December in Wuhan, China, made more than 203,456,777 people sick worldwide and killed at least 4.3 million people, according to Worldometer data as of August 9th, 2021. There have been around 36,543,338 confirmed cases of COVID-19 in the United States, with 633,116 deaths. The COVID-19 pandemic had brought technological changes that are critical to better care. The prolonged shut-in situation is devastating news for countless industries impacted by business closures, but there are bright spots for sectors that have thrived amid the global health crisis so far. Lymphedema Treatment is one sector that has showed remarkable stamina. According to Marry Ann Libert, the COVID-19 lockdown had a great impact on lymphedema patients in both medical and psychological aspects across the US.

The overall North America lymphedema treatment market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast of the North America lymphedema treatment market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data and gain more analytical insights into the topic. The participants typically involved in this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the North America lymphedema treatment market. 3M Company, Bio Compression Systems Inc., BSN medical GmbH, Huntleigh Healthcare Limited, Lohmann & Rauscher GmbH & Co. KG, Mego Afek ltd, Sigvaris Group, Smith & Nephew, Tactile Medical, and ThermoTek are a few key players operating in the market in this region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America lymphedema treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America lymphedema treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the lymphedema treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution